Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.
Kato T, Manabe RI, Igarashi H, Kametani F, Hirokawa S, Sekine Y, Fujita N, Saito S, Kawashima Y, Hatano Y, Ando S, Nozaki H, Sugai A, Uemura M, Fukunaga M, Sato T, Koyama A, Saito R, Sugie A, Toyoshima Y, Kawata H, Murayama S, Matsumoto M, Kakita A, Hasegawa M, Ihara M, Kanazawa M, Nishizawa M, Tsuji S, Onodera O. Kato T, et al. Among authors: murayama s. J Clin Invest. 2021 Nov 15;131(22):e140555. doi: 10.1172/JCI140555. J Clin Invest. 2021. PMID: 34779414 Free PMC article.
Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains.
Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, Hasegawa M. Taniguchi S, et al. Among authors: murayama s. FEBS Lett. 2001 Jan 26;489(1):46-50. doi: 10.1016/s0014-5793(00)02431-5. FEBS Lett. 2001. PMID: 11231011 Free article.
Unique tauopathy in Fukuyama-type congenital muscular dystrophy.
Saito Y, Motoyoshi Y, Kashima T, Izumiyama-Shimomura N, Toda T, Nakano I, Hasegawa M, Murayama S. Saito Y, et al. Among authors: murayama s. J Neuropathol Exp Neurol. 2005 Dec;64(12):1118-26. doi: 10.1097/01.jnen.0000190069.10633.c2. J Neuropathol Exp Neurol. 2005. PMID: 16319722
A 52-year-old man with hypohidrosis.
Shimizu J, Hashimoto M, Murayama S, Tsuji S. Shimizu J, et al. Among authors: murayama s. Neuropathology. 2006 Dec;26(6):592-4. doi: 10.1111/j.1440-1789.2006.00716.x. Neuropathology. 2006. PMID: 17203598 No abstract available.
Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.
Takahashi Y, Seki N, Ishiura H, Mitsui J, Matsukawa T, Kishino A, Onodera O, Aoki M, Shimozawa N, Murayama S, Itoyama Y, Suzuki Y, Sobue G, Nishizawa M, Goto J, Tsuji S. Takahashi Y, et al. Among authors: murayama s. Arch Neurol. 2008 Oct;65(10):1326-32. doi: 10.1001/archneur.65.10.1326. Arch Neurol. 2008. PMID: 18852346
Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum.
Takahashi M, Ishikawa K, Sato N, Obayashi M, Niimi Y, Ishiguro T, Yamada M, Toyoshima Y, Takahashi H, Kato T, Takao M, Murayama S, Mori O, Eishi Y, Mizusawa H. Takahashi M, et al. Among authors: murayama s. Neuropathology. 2012 Dec;32(6):595-603. doi: 10.1111/j.1440-1789.2012.01302.x. Epub 2012 Mar 7. Neuropathology. 2012. PMID: 22393909
Molecular analysis and biochemical classification of TDP-43 proteinopathy.
Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao M, Saito Y, Murayama S, Akiyama H, Hasegawa M, Mann DM, Tamaoka A. Tsuji H, et al. Among authors: murayama s. Brain. 2012 Nov;135(Pt 11):3380-91. doi: 10.1093/brain/aws230. Epub 2012 Oct 3. Brain. 2012. PMID: 23035040
[Prion-like protein propagation in neurodegenerative diseases].
Hasegawa M, Nonaka T, Suzukake M, Tsuji H, Tamaoka A, Yoshida M, Murayama S, Arai T, Akiyama H. Hasegawa M, et al. Among authors: murayama s. Rinsho Shinkeigaku. 2012;52(11):1325-6. doi: 10.5692/clinicalneurol.52.1325. Rinsho Shinkeigaku. 2012. PMID: 23196606 Japanese. No abstract available.
ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.
Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, Belzil VV, Dion PA, Higasa K, Doi K, Ishiura H, Mitsui J, Date H, Ahsan B, Matsukawa T, Ichikawa Y, Moritoyo T, Ikoma M, Hashimoto T, Kimura F, Murayama S, Onodera O, Nishizawa M, Yoshida M, Atsuta N, Sobue G; JaCALS; Fifita JA, Williams KL, Blair IP, Nicholson GA, Gonzalez-Perez P, Brown RH Jr, Nomoto M, Elenius K, Rouleau GA, Fujiyama A, Morishita S, Goto J, Tsuji S. Takahashi Y, et al. Among authors: murayama s. Am J Hum Genet. 2013 Nov 7;93(5):900-5. doi: 10.1016/j.ajhg.2013.09.008. Epub 2013 Oct 10. Am J Hum Genet. 2013. PMID: 24119685 Free PMC article.
1,133 results